Found: 16
Select item for more details and to access through your institution.
Efficacy of Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against Infection from SARS-CoV-2 and Severe COVID-19 among Heavily Immunocompromised Patients: A Single-Center, Prospective, Real-World Study.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 8, p. 1345, doi. 10.3390/v16081345
- By:
- Publication type:
- Article
Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia.
- Published in:
- Medicine International (2754-3242), 2023, v. 3, n. 4, p. 1, doi. 10.3892/mi.2023.94
- By:
- Publication type:
- Article
Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula.
- Published in:
- Canadian Respiratory Journal, 2023, p. 1, doi. 10.1155/2023/7474564
- By:
- Publication type:
- Article
Prevalence of abnormal liver biochemistry and its impact on COVID-19 patients' outcomes: a single-center Greek study.
- Published in:
- Annals of Gastroenterology, 2022, v. 35, n. 3, p. 290, doi. 10.20524/aog.2022.0709
- By:
- Publication type:
- Article
The effectiveness of a community-based, type 2 diabetes prevention programme on health-related quality of life. The DE-PLAN study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 10, p. 1, doi. 10.1371/journal.pone.0221467
- By:
- Publication type:
- Article
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application.
- Published in:
- Liver International, 2015, v. 35, n. 11, p. 2458, doi. 10.1111/liv.12841
- By:
- Publication type:
- Article
A Simple Prognostic Score for Critical COVID-19 Derived from Patients without Comorbidities Performs Well in Unselected Patients.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1810, doi. 10.3390/jcm11071810
- By:
- Publication type:
- Article
Risk factors for the in‑hospital and 1‑year mortality of elderly patients hospitalized due to COVID‑19‑related pneumonia.
- Published in:
- Experimental & Therapeutic Medicine, 2024, v. 27, n. 1, p. N.PAG, doi. 10.3892/etm.2023.12310
- By:
- Publication type:
- Article
Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study.
- Published in:
- Experimental & Therapeutic Medicine, 2023, v. 26, n. 4, p. N.PAG, doi. 10.3892/etm.2023.12161
- By:
- Publication type:
- Article
Predictors of COVID-19-associated mortality among hospitalized elderly patients with dementia.
- Published in:
- Experimental & Therapeutic Medicine, 2023, v. 26, n. 2, p. 1, doi. 10.3892/etm.2023.12094
- By:
- Publication type:
- Article
Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study.
- Published in:
- Experimental & Therapeutic Medicine, 2022, v. 24, n. 6, p. N.PAG, doi. 10.3892/etm.2022.11660
- By:
- Publication type:
- Article
Biomarkers predicting the 30‑day mortality of patients who underwent elective surgery and were infected with SARS‑CoV‑2 during the post‑operative period: A retrospective study.
- Published in:
- Experimental & Therapeutic Medicine, 2022, v. 24, n. 5, p. N.PAG, doi. 10.3892/etm.2022.11629
- By:
- Publication type:
- Article
Acute hepatitis and liver injury in hospitalized patients with COVID‑19 infection.
- Published in:
- Experimental & Therapeutic Medicine, 2022, v. 24, n. 5, p. N.PAG, doi. 10.3892/etm.2022.11627
- By:
- Publication type:
- Article
Onodera's prognostic nutritional index: Comparison of its role in the severity and outcomes of patients with COVID‑19 during the periods of alpha, delta and omicron variant predominance.
- Published in:
- Experimental & Therapeutic Medicine, 2022, v. 24, n. 5, p. N.PAG, doi. 10.3892/etm.2022.11611
- By:
- Publication type:
- Article
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 7, p. 1515, doi. 10.3390/v15071515
- By:
- Publication type:
- Article